Editorial: EU must rethink vaccine strategy after its misstep

By underestimating the logistics of a mass vaccination rollout, European leaders risk failing their citizens on this vital issue

31st January, 2021
Editorial: EU must rethink vaccine strategy after its misstep
AstraZeneca got into a row with the US Food and Drug Administration over the conduct of a clinical trial

AstraZeneca has made few friends in the weeks since it unveiled a Covid-19 vaccine along with Oxford University. Since that joint achievement, the vaccine has been clouded by doubts, and an impression that the Anglo-Swedish pharmaceutical company’s focus is as much on the stock market as on the pandemic.

During testing of the vaccine, AstraZeneca got into a row with the US Food and Drug Administration over the conduct of a clinical trial....

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Editorial: We all need to be ambitious in our fight against climate change

Editorial: North’s leaders have a duty to address the causes of disturbing street violence

Editorial: Standing still on infrastructure is simply not an option

Editorial: Biden’s plan puts Irish corporate tax regime back into focus again